| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 18:31:07 UTC |
|---|
| Update Date | 2021-09-26 23:13:56 UTC |
|---|
| HMDB ID | HMDB0257511 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | 1-(1-Methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea |
|---|
| Description | 1-(1-methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea, also known as 3-(3-methyl-1,2-thiazol-5-yl)-1-(1-methylindol-5-yl)urea or SB 204741, belongs to the class of organic compounds known as n-alkylindoles. N-alkylindoles are compounds containing an indole moiety that carries an alkyl chain at the 1-position. Based on a literature review a significant number of articles have been published on 1-(1-methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea. This compound has been identified in human blood as reported by (PMID: 31557052 ). 1-(1-methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 1-(1-Methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CN1C=CC2=C1C=CC(NC(=O)NC1=CC(C)=NS1)=C2 InChI=1S/C14H14N4OS/c1-9-7-13(20-17-9)16-14(19)15-11-3-4-12-10(8-11)5-6-18(12)2/h3-8H,1-2H3,(H2,15,16,19) |
|---|
| Synonyms | | Value | Source |
|---|
| 3-(3-Methyl-1,2-thiazol-5-yl)-1-(1-methylindol-5-yl)urea | ChEBI | | N-(1-Methyl-1H-5-indolyl)-n'-(3-methyl-5-isothiazolyl)urea | ChEBI | | N-(1-Methyl-5-indolyl)-n'-(3-methyl-5-isothiazolyl)urea | ChEBI | | SB 204741 | ChEBI | | SB-204741 | ChEBI | | SB204741 | ChEBI | | MIMIU | MeSH |
|
|---|
| Chemical Formula | C14H14N4OS |
|---|
| Average Molecular Weight | 286.35 |
|---|
| Monoisotopic Molecular Weight | 286.088832261 |
|---|
| IUPAC Name | 3-(3-methyl-1,2-thiazol-5-yl)-1-(1-methyl-1H-indol-5-yl)urea |
|---|
| Traditional Name | 3-(3-methyl-1,2-thiazol-5-yl)-1-(1-methylindol-5-yl)urea |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CN1C=CC2=C1C=CC(NC(=O)NC1=CC(C)=NS1)=C2 |
|---|
| InChI Identifier | InChI=1S/C14H14N4OS/c1-9-7-13(20-17-9)16-14(19)15-11-3-4-12-10(8-11)5-6-18(12)2/h3-8H,1-2H3,(H2,15,16,19) |
|---|
| InChI Key | USFUFHFQWXDVMH-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as n-alkylindoles. N-alkylindoles are compounds containing an indole moiety that carries an alkyl chain at the 1-position. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Indoles and derivatives |
|---|
| Sub Class | N-alkylindoles |
|---|
| Direct Parent | N-alkylindoles |
|---|
| Alternative Parents | |
|---|
| Substituents | - N-alkylindole
- Indole
- N-methylpyrrole
- Substituted pyrrole
- Benzenoid
- Azole
- Pyrrole
- Heteroaromatic compound
- Thiazole
- Carbonic acid derivative
- Urea
- Azacycle
- Hydrocarbon derivative
- Organic oxide
- Organooxygen compound
- Organonitrogen compound
- Organopnictogen compound
- Organic oxygen compound
- Carbonyl group
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 4.58 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 12.136 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.01 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1772.5 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 313.4 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 81.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 182.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 91.9 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 308.8 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 329.6 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 138.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 748.5 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 51.5 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1019.2 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 342.4 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 272.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 438.6 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 351.6 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 168.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 1-(1-Methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea,1TMS,isomer #1 | CC1=NSC(NC(=O)N(C2=CC=C3C(=C2)C=CN3C)[Si](C)(C)C)=C1 | 2956.0 | Semi standard non polar | 33892256 | | 1-(1-Methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea,1TMS,isomer #1 | CC1=NSC(NC(=O)N(C2=CC=C3C(=C2)C=CN3C)[Si](C)(C)C)=C1 | 2786.2 | Standard non polar | 33892256 | | 1-(1-Methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea,1TMS,isomer #1 | CC1=NSC(NC(=O)N(C2=CC=C3C(=C2)C=CN3C)[Si](C)(C)C)=C1 | 4128.2 | Standard polar | 33892256 | | 1-(1-Methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea,1TMS,isomer #2 | CC1=NSC(N(C(=O)NC2=CC=C3C(=C2)C=CN3C)[Si](C)(C)C)=C1 | 2870.8 | Semi standard non polar | 33892256 | | 1-(1-Methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea,1TMS,isomer #2 | CC1=NSC(N(C(=O)NC2=CC=C3C(=C2)C=CN3C)[Si](C)(C)C)=C1 | 2756.5 | Standard non polar | 33892256 | | 1-(1-Methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea,1TMS,isomer #2 | CC1=NSC(N(C(=O)NC2=CC=C3C(=C2)C=CN3C)[Si](C)(C)C)=C1 | 3843.9 | Standard polar | 33892256 | | 1-(1-Methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea,2TMS,isomer #1 | CC1=NSC(N(C(=O)N(C2=CC=C3C(=C2)C=CN3C)[Si](C)(C)C)[Si](C)(C)C)=C1 | 2749.0 | Semi standard non polar | 33892256 | | 1-(1-Methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea,2TMS,isomer #1 | CC1=NSC(N(C(=O)N(C2=CC=C3C(=C2)C=CN3C)[Si](C)(C)C)[Si](C)(C)C)=C1 | 2799.2 | Standard non polar | 33892256 | | 1-(1-Methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea,2TMS,isomer #1 | CC1=NSC(N(C(=O)N(C2=CC=C3C(=C2)C=CN3C)[Si](C)(C)C)[Si](C)(C)C)=C1 | 3319.4 | Standard polar | 33892256 | | 1-(1-Methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea,1TBDMS,isomer #1 | CC1=NSC(NC(=O)N(C2=CC=C3C(=C2)C=CN3C)[Si](C)(C)C(C)(C)C)=C1 | 3209.7 | Semi standard non polar | 33892256 | | 1-(1-Methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea,1TBDMS,isomer #1 | CC1=NSC(NC(=O)N(C2=CC=C3C(=C2)C=CN3C)[Si](C)(C)C(C)(C)C)=C1 | 2980.8 | Standard non polar | 33892256 | | 1-(1-Methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea,1TBDMS,isomer #1 | CC1=NSC(NC(=O)N(C2=CC=C3C(=C2)C=CN3C)[Si](C)(C)C(C)(C)C)=C1 | 4107.6 | Standard polar | 33892256 | | 1-(1-Methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea,1TBDMS,isomer #2 | CC1=NSC(N(C(=O)NC2=CC=C3C(=C2)C=CN3C)[Si](C)(C)C(C)(C)C)=C1 | 3131.1 | Semi standard non polar | 33892256 | | 1-(1-Methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea,1TBDMS,isomer #2 | CC1=NSC(N(C(=O)NC2=CC=C3C(=C2)C=CN3C)[Si](C)(C)C(C)(C)C)=C1 | 2960.5 | Standard non polar | 33892256 | | 1-(1-Methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea,1TBDMS,isomer #2 | CC1=NSC(N(C(=O)NC2=CC=C3C(=C2)C=CN3C)[Si](C)(C)C(C)(C)C)=C1 | 3800.1 | Standard polar | 33892256 | | 1-(1-Methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea,2TBDMS,isomer #1 | CC1=NSC(N(C(=O)N(C2=CC=C3C(=C2)C=CN3C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1 | 3226.7 | Semi standard non polar | 33892256 | | 1-(1-Methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea,2TBDMS,isomer #1 | CC1=NSC(N(C(=O)N(C2=CC=C3C(=C2)C=CN3C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1 | 3190.7 | Standard non polar | 33892256 | | 1-(1-Methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea,2TBDMS,isomer #1 | CC1=NSC(N(C(=O)N(C2=CC=C3C(=C2)C=CN3C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1 | 3426.4 | Standard polar | 33892256 |
|
|---|